SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response

SF3B1 hotspot mutations are associated with a poor prognosis in several tumor types and lead to global disruption of canonical splicing. Through synthetic lethal drug screens, we identify that SF3B1 mutant ( SF3B1 MUT ) cells are selectively sensitive to poly (ADP-ribose) polymerase inhibitors (PARP...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Nature genetics Ročník 55; číslo 8; s. 1311 - 1323
Hlavní autori:	Bland, Philip, Saville, Harry, Wai, Patty T., Curnow, Lucinda, Muirhead, Gareth, Nieminuszczy, Jadwiga, Ravindran, Nivedita, John, Marie Beatrix, Hedayat, Somaieh, Barker, Holly E., Wright, James, Yu, Lu, Mavrommati, Ioanna, Read, Abigail, Peck, Barrie, Allen, Mark, Gazinska, Patrycja, Pemberton, Helen N., Gulati, Aditi, Nash, Sarah, Noor, Farzana, Guppy, Naomi, Roxanis, Ioannis, Pratt, Guy, Oldreive, Ceri, Stankovic, Tatjana, Barlow, Samantha, Kalirai, Helen, Coupland, Sarah E., Broderick, Ronan, Alsafadi, Samar, Houy, Alexandre, Stern, Marc-Henri, Pettit, Stephen, Choudhary, Jyoti S., Haider, Syed, Niedzwiedz, Wojciech, Lord, Christopher J., Natrajan, Rachael
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	New York Nature Publishing Group US 01.08.2023 Nature Publishing Group
Predmet:	13/106 13/51 13/89 631/1647/2217 631/208/212/2019 631/208/212/2166 631/67/1484 631/67/1990/283/1895 64/60 82/58 96/106 96/109 96/95 Adenosine diphosphate Agriculture Animal Genetics and Genomics Anticancer properties Antitumor activity Ataxia Biomarkers Biomedical and Life Sciences Biomedicine BRCA1 Protein - genetics Cancer Cancer Research Cell cycle Cell Line, Tumor CHK1 protein Cyclin-dependent kinase Cyclin-dependent kinase 2 Cyclin-dependent kinases DNA biosynthesis Drug screening Gene Function Genes Genomes Homologous recombination Human Genetics Humans In vivo methods and tests Intermediates Kinases Leukemia Medical prognosis Melanoma Metastases Mutation Mutation hot spots Neoplasms - drug therapy Neoplasms - genetics Phosphoproteins - genetics Poly(ADP-ribose) polymerase Poly(ADP-ribose) Polymerase Inhibitors - pharmacology Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use Protein expression Proteins Replication Replication origins Ribose RNA Splicing Factors - genetics Transcription Factors - genetics Tumors
ISSN:	1061-4036, 1546-1718, 1546-1718
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!